Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today
Key Stats
- $138.78BMarket Cap
- -Volume
- HealthSector
- $552.8552W High
- $376.6252W Low
- -Typical Hold Time
- $132.91BEnterprise Value
- -Div Yield
- -Trading Activity
Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $376.62 and a high of $552.85, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
Trump praises Micron amid Nvidia's $279B memory purchase surge driven by AI demand.
President Trump called Micron Technology one of the world's "hottest" companies following Nvidia's announcement of $279 billion in supplier commitments, mostly for AI-related memory. Nvidia's Q2 revenue doubled year-over-year, with memory prices risi...
Berkshire Hathaway bets $6.8B on housing amid weakening U.S. market demand signals
Berkshire Hathaway, under CEO Greg Abel, has significantly increased its housing market exposure by acquiring Taylor Morrison Home for $6.8 billion and boosting stakes in Lennar and D.R. Horton. This move comes as U.S. housing demand weakens, with pe...
Chevron's dividend looks safer than PepsiCo's amid different financial pressures.
Chevron and PepsiCo both raised dividends in 2026, but face different challenges. Chevron benefits from strong cash flow and debt reduction due to a commodity cycle, making its dividend more secure despite market fluctuations. PepsiCo struggles with ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.